Impact of subjective sleep quality on glycemic control in type 2 diabetes mellitus

Family Practice

Volumn 29, Issue 1, 2012, Pages 30-35

  Tsai, Yi Wen ^a,b   Kann, Nai Hsuan ^c   Tung, Tao Hsin ^c,d   Chao, Yi Jen ^a,b   Lin, Chin Jung ^e   Chang, Ko Chen ^a,b   Chang, Shy Shin ^a,b   Chen, Jau Yuan ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^e TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Diabetes mellitus; Glycaemic control; HbA1C; PSQI; Sleep quality

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE; AGED; ARTICLE; ASIAN; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; FEMALE; GENDER; GLYCEMIC CONTROL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PITTSBURGH SLEEP QUALITY INDEX; SLEEP QUALITY;

EID: 84862958989     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmr041     Document Type: Article

References (29)

1. Aikens JE, Rouse ME. Help-seeking for insomnia among adult patientsin primary care. J Am Board Fam Pract 2005; 18: 257-61.
2. Terzano MG, Parrino L, Cirignotta F et al. Studio Morfeo: insomnia in primary care, a survey conducted on the Italian population. Sleep Med 2004; 5: 67-75.
3. Shochat T, Umphress J, Israel AG, Ancoli-Israel S. Insomnia in primary care patients. Sleep 1999; 22 (suppl 2): S359-65.
4. Gangwisch JE, Heymsfield SB, Boden-Albala B et al. Short sleep duration as a risk factor for hypertension: analysis of the first National Health and Nutrition Examination Survey. Hypertension 2006; 47: 833-9.
5. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analysis of the NHANES I. Sleep 2005; 28: 1289-96.
6. Hasler G, Buyse D, Klaghofer R et al. The association between short sleep duration and obesity in young adults: a13-year prospective study. Sleep 2004; 27: 661-6.
7. King CR, Knutson KL, Rathouz PJ et al. Short sleep duration and incident coronary artery calcification. JAMA 2008; 300: 2859-66.
8. Ayas NT, White DP, Manson JE et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003; 163: 205-9.
9. Zisapel N. Sleep and sleep disturbances: biological basis and clinical implications. Cell Mol Life Sci 2007; 64: 1174-86.
10. Knutson KL, Spiegel K, Penev P, Van Cauter E. The metabolic consequences of sleep deprivation. Sleep Med Rev 2007; 11: 163-78.
11. Hayashino Y, Fukuhara S, Suzukamo et al. Relation between sleep quality and quantity, quality of life, and risk of developing diabetes in healthy workers in Japan: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study. BMC Public Health 2007; 7: 129.
12. Nakajima H, Kaneita Y, Yokoyama E et al. Association between sleep duration and hemoglobin A1c level. Sleep Med 2008; 9: 745-52.
13. Chiasson JL, Josse RG, Gomis R et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003; 290: 486-94.
14. Gaede P, Vedel P, Larsen N et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-93.
15. Summary of revisions for the 2010 Clinical Practice Recommendations. Diabetes Care 2010; 33 (suppl 1): S3.
16. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 854-65.
17. Ohkubo Y, Kishikawa H, Araki E et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Prac 1995; 28: 103-17.
18. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS 33) UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-53.
19. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
20. Griffin JA, Gilliland SS, Perez G, Helitzer D, Carter JS. Participant satisfaction with a culturally appropriate diabetes education program: the Native American Diabetes Education Project. Diabetes Educ 1999; 25: 351-66.
21. Skinner TC, Cradock S, Arundel F, Graham W. Lifestyle and behavior: four theories and a philosophy: self-management education for individuals newly diagnosed with type 2 diabetes. Diabetes Spectr 2003; 16: 75-80.
22. Gamm LD. Advancing community health through community health partnerships. J Healthc Manag 1998; 43: 51-67.
23. Department of Health, Executive Yuan, ROC 2002. http:// www.doh.gov.tw (accessed on July 2011).
24. Trento M, Broglio F, Riganti F et al. Sleep abnormalities in type 2 diabetes may be associated with glycemic control. Acta Diabetol 2008; 45: 225-9.
25. Spiegel K, Leproult R, Van Cauter EV. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435-9.
26. Hjemdahl P. Stress and metabolic syndrome: an interesting but enigmatic association. Circulation 2002; 106: 2634-6.
27. Spiegel K, Knutson K, Leproult R, Tasali E, Cauter EV. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 2005; 99: 2008-19.
28. The effect of intensive treatment of diabetes on the development and progression of long-termcomplications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-86.
29. Knutson KL, Ryden AM, Mander BA, Van Cauter E. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006; 166: 1768-74.